STMN1 and ovarian carcinoma: In studies of Alli et al. and Balachandran et al. [11, 12] carried on breast and ovarian cancer cell lines, it was demonstrated that the increased expression of STMN1 had reduced microtubule polymerization (which significantly reduced binding of paclitaxel).